Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 26.10.2026 1 Ann Intern Med 2 BMJ 1 Clin Microbiol Rev 1 Indian Pediatr 1 J Infect 4 J Virol 2 Nat Med 3 Pediatrics 1 PLoS Med 2 PLoS One 1 Science 9 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. PIKE J, Holzinger N, Xiao HT, Stanislawski E, et al
   Economic Impact of the 2025 New Mexico Measles Outbreak: Highlighting the Cost of Efforts to Prevent Future Outbreaks.
   Ann Intern Med. 2026;179:1369-1374.
   PubMed         Abstract available
   
   

   
   BMJ

2. FURNEAUX R
   Measles: "Stagnant" vaccine coverage has led to global resurgence, analysis finds.
   BMJ. 2026;395:e101230.
   PubMed        
   
   
3. MAHASE E
   Chikungunya vaccine withdrawn after safety review.
   BMJ. 2026;395:e101215.
   PubMed        
   
   

   
   Clin Microbiol Rev

4. MILLS E, Del Borgo MP, O'Keeffe M
   Solving the Staphylococcus aureus puzzle: lessons to guide future MRSA vaccine development.
   Clin Microbiol Rev. 2026 Oct 21:e0011226. doi: 10.1128/cmr.00112.
   PubMed         Abstract available
   
   

   
   Indian Pediatr

5. VASHISHTHA VM
   BCG at 100: The Paradox of an Indispensable Vaccine.
   Indian Pediatr. 2026 Oct 22. doi: 10.1007/s13312-026-00433.
   PubMed         Abstract available
   
   

   
   J Infect

6. ORTEGA-FRANCISCO S, Prudente de Aquino MT, Chiuppesi F, Gutierrez-Franco MA Jr, et al
   Phase 2 evaluation of two GEO-CM04S1 dose levels shows comparable safety and broad immunogenicity.
   J Infect. 2026;93:106855.
   PubMed         Abstract available
   
   

   
   J Virol

7. SUN J, Wang J, Li K, Wei D, et al
   Generation and characterization of a PRRSV-2 DIVA marker virus by deletion of a novel epitope in the nucleocapsid protein.
   J Virol. 2026;100:e0125926.
   PubMed         Abstract available
   
   
8. ZHANG Q-Y, Zhang Z-R, Deng C-L, Wang J, et al
   Internal poly(A) replacement strategy within 3' UTR for live-attenuated tick-borne encephalitis virus.
   J Virol. 2026;100:e0078126.
   PubMed         Abstract available
   
   
9. KIRK J, Sives S, Rayment A, Tappin A, et al
   Spike protein derived from an apathogenic IBV strain confers attenuated phenotype to a nephropathogenic IBV strain.
   J Virol. 2026 Sep 10:e0110326. doi: 10.1128/jvi.01103.
   PubMed         Abstract available
   
   
10. BHAVSAR D, Civljak A, Bonnettaz B, Arunkumar GA, et al
    Broadly reactive antibodies against influenza B virus hemagglutinin neutralize and protect through distinct structural mechanisms.
    J Virol. 2026 Sep 4:e0080226. doi: 10.1128/jvi.00802.
    PubMed         Abstract available
    
    

    
    Nat Med

11. 
    Global and regional burden of measles and vaccine coverage among children under 5 years, 1990-2023: a Global Burden of Disease Study.
    Nat Med. 2026 Oct 21. doi: 10.1038/s41591-026-04661.
    PubMed         Abstract available
    
    
12. WINTER AK, Ferrari MJ
    The need for resilience in global vaccination programs.
    Nat Med. 2026 Oct 21. doi: 10.1038/s41591-026-04690.
    PubMed        
    
    

    
    Pediatrics

13. SHAPIRO JR, Dorogy AD, Science M, Gupta S, et al
    Vaccine-Induced Antibody and T Cell Immunity to Measles and Varicella in Children With ALL.
    Pediatrics. 2026 Oct 22:e2025075651. doi: 10.1542/peds.2025-075651.
    PubMed        
    
    
14. ESTEBAN RIERA I, Perez-Caballero R, Natalini Martinez S, Gonzalez-Amores M, et al
    Immunogenicity and Safety of PHH-1V COVID-19 Vaccine as a Heterologous Booster in Adolescents.
    Pediatrics. 2026 Oct 23:e2026076225. doi: 10.1542/peds.2026-076225.
    PubMed         Abstract available
    
    
15. HIGGINS DM, Gurfinkel D, Dorsey B, O'Leary ST, et al
    Frontline Staff Vaccine Communication During Pediatric Well-Child Encounters: A Mixed-Methods Study.
    Pediatrics. 2026 Oct 23:e2026077450. doi: 10.1542/peds.2026-077450.
    PubMed         Abstract available
    
    

    
    PLoS Med

16. AMIN AB, Garcia Quesada M, Trudell D, Dean NE, et al
    Analysis of the impact of naturally-acquired immunity on Shigella vaccine performance to inform clinical trials: A simulation-based modeling study.
    PLoS Med. 2026;23:e1004878.
    PubMed         Abstract available
    
    

    
    PLoS One

17. RAHMAN MA, Kabir L, Ahmed N, Barua A, et al
    Immunoinformatics and reverse vaccinology design of self-amplifying RNA vaccine against marburg virus with structural dynamics and immune simulation analysis.
    PLoS One. 2026;21:e0361136.
    PubMed         Abstract available
    
    
18. 
    Retraction: A comprehensive survey on the beliefs, perceptions, and clinical manifestations of pre and post Covid-19 vaccinations among physiotherapy students in the United Arab Emirates.
    PLoS One. 2026;21:e0360878.
    PubMed        
    
    

    
    Science

19. KUPFERSCHMIDT K
    Vaccine trial is a ray of hope in Congo's Ebola epidemic.
    Science. 2026;394:364-365.
    PubMed         Abstract available
    
    

    
    Vaccine

20. PLESS LL, Griffith MP, Waggle KD, Coyle H, et al
    In silico conservation and HLA-binding profiles of HMPV F and G protein epitopes: implications for universal vaccine development.
    Vaccine. 2026;95:129282.
    PubMed         Abstract available
    
    
21. XU S, Sy LS, Hong V, Farrington P, et al
    Ischemic stroke after bivalent mRNA COVID-19 vaccination and influenza vaccination during the 2022-2023 season: a multi-site self-controlled case series study.
    Vaccine. 2026;95:129263.
    PubMed         Abstract available
    
    
22. YODAWARA C, Iio Y, Ejiri H, Mori Y, et al
    Sex differences in human papillomavirus vaccination among Japanese university students and associated factors: a cross-sectional study examining the mediating effect of knowledge and interactions.
    Vaccine. 2026;95:129276.
    PubMed         Abstract available
    
    
23. HAYASHI Y, Abbas K, Dhoubhadel BG
    Development and analytical characterization of a 24-plex microsphere-based assay for the quantitation of the antibodies against pneumococcal vaccine serotypes.
    Vaccine. 2026;94:129266.
    PubMed         Abstract available
    
    
24. BRAVO L, Bermal N, Alberto E, Pardo JA, et al
    Phase 2 trial to evaluate the safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine (IVT-PCV25) in infants.
    Vaccine. 2026;94:129268.
    PubMed         Abstract available
    
    
25. KAHN JA, Ermel A, Ding L, DeSieghardt A, et al
    Cross-protection and type-replacement over the 17 years after human papillomavirus vaccine introduction in young women.
    Vaccine. 2026;94:129244.
    PubMed         Abstract available
    
    
26. CAI Z, Wang L, Ji S, Deng X, et al
    Quantifying the impact of pathogen interactions on vaccine effectiveness estimates in the test-negative design.
    Vaccine. 2026;94:129265.
    PubMed         Abstract available
    
    
27. SMITH KJ, Wateska AR, Yi Z, Zimmerman RK, et al
    When models diverge: Harmonizing pneumococcal vaccination cost-effectiveness analyses to inform PCV20 and PCV21 use in US adults.
    Vaccine. 2026;94:129267.
    PubMed         Abstract available
    
    
28. MUTWADI MALEMBE A, Nkamba Mukadi D, Hoff NA, Merritt S, et al
    Timeliness of routine childhood vaccination in the Democratic Republic of the Congo: data from national vaccine surveys in 2021/2022, 2023 and 2024.
    Vaccine. 2026;94:129222.
    PubMed         Abstract available
    
    

    
    Virus Res

29. SINGH H, Tatte VS, Kaushal H
    Epigenetics of HFRS: Linking Immunity, Pathogenesis, and Vaccine-Induced Protection.
    Virus Res. 2026 Oct 22:199820. doi: 10.1016/j.virusres.2026.199820.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum